CVS Health Corporation (ETR:CVS)
67.85
-0.66 (-0.96%)
Nov 7, 2025, 5:35 PM CET
CVS Health Revenue
CVS Health had revenue of $102.24B USD in the quarter ending September 30, 2025, with 7.76% growth. This brings the company's revenue in the last twelve months to $391.69B, up 6.66% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$391.69B
Revenue Growth
+6.66%
P/S Ratio
0.26
Revenue / Employee
$1.31M
Employees
300,000
Market Cap
86.60B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
CVS Health News
- 3 days ago - Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies - Business Wire
- 4 days ago - Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Nasdaq
- 6 days ago - CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS ... - GuruFocus
- 6 days ago - Validea Detailed Fundamental Analysis - CVS - Nasdaq
- 6 days ago - CVS Health: Undervalued And Ripe For Growth - Seeking Alpha
- 9 days ago - CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity - PRNewsWire
- 9 days ago - What the Options Market Tells Us About CVS Health - Benzinga
- 10 days ago - CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Outperform Rating | CVS Stock News - GuruFocus